GBS Inc (GBS) Stock
GBS is no longer traded. GBS was delisted from the Nasdaq in January 2023.
Prices on this page are historical; the last trade was January 24, 2023 at $1.19.
GBS stock price history
GBS final trading statistics
- Final close
- $1.19
- Final trading day
- Jan 24, 2023
- Market cap at delisting
- $7.05M
- Shares outstanding
- 14.89M
- Final 52-week range
- $0.17 – $1.60
- Avg. volume (final 3 mo.)
- 2,969,284
- All-time high (split-adj.)
- $220.40 · Dec 2020
- All-time low (split-adj.)
- $3.86 · Dec 2022
- Return since IPO
- -89.2%
- Beta
- —
- Book value / share
- $0.45
- Price / book
- 2.67
GBS annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $437.15M | -$8.3M | -$0.73 |
| FY2021 | $1.98M | -$7.0M | -$0.69 |
| FY2020 | $0.00 | -$3.1M | -$0.28 |
| FY2019 | $0.00 | -$7.3M | -$0.91 |
| FY2018 | $0.00 | -$5.0M | -$0.69 |
Last five fiscal years reported before the delisting; fiscal year ending June. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About GBS Inc
GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
GBS stock FAQ
What happened to GBS stock?
GBS stock was delisted from the Nasdaq. Its final close was $1.19 on January 24, 2023.
Is GBS stock still trading?
No. GBS was delisted from the Nasdaq in January 2023 and no longer trades on a U.S. exchange.
What was the last price of GBS stock?
GBS closed at $1.19 on its final trading day, January 24, 2023, for a market value of about $7.05M.
What were GBS's revenue and earnings in its last full fiscal year?
GBS reported revenue of $437.15M and net income of -$8.3M in fiscal 2022, its last full year as a public company.
When did GBS go public?
GBS Inc stock began trading on December 23, 2020.